As of 10:30 AM on the 10th, Engchem Life Sciences is trading at 155,600 KRW, up 7.68% from the previous day. This represents a 78.65% increase compared to July 16. Engchem Life Sciences is known as a global new drug development and active pharmaceutical ingredient company.
Today, foreigners have a net purchase of 1,000 shares of Engchem Life Sciences, while institutions have a net sale of 3,000 shares, according to provisional data. Over the past 5 days, individual investors have net purchased 156,828 shares, while foreigners and institutions have net sold 48,944 shares and 93,219 shares respectively.
On August 7, Engchem Life Sciences was a market topic for its "uptrend following FDA approval of Phase 2 clinical trials for a COVID-19 treatment."

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
